Gerald W. Dryden

4.0k total citations · 2 hit papers
67 papers, 1.6k citations indexed

About

Gerald W. Dryden is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Gerald W. Dryden has authored 67 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 15 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Gerald W. Dryden's work include Inflammatory Bowel Disease (18 papers), Colorectal Cancer Screening and Detection (7 papers) and Tea Polyphenols and Effects (7 papers). Gerald W. Dryden is often cited by papers focused on Inflammatory Bowel Disease (18 papers), Colorectal Cancer Screening and Detection (7 papers) and Tea Polyphenols and Effects (7 papers). Gerald W. Dryden collaborates with scholars based in United States, China and Israel. Gerald W. Dryden's co-authors include Craig J. McClain, Jun Yan, Jingyao Mu, Stephen A. McClave, Lifeng Zhang, Donald M. Miller, Qilong Wang, Baomei Wang, Xiaoyu Xiang and Huang-Ge Zhang and has published in prestigious journals such as Circulation, The Journal of Immunology and Gastroenterology.

In The Last Decade

Gerald W. Dryden

61 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeted Drug Delivery to Intestinal Macrophages by Bioactive Nanovesicles Released from Grapefruit

2013 460 citations Baomei Wang, Xiaoying Zhuang et al. Molecular Therapy profile →
Garlic exosome-like nanoparticles reverse high-fat diet induced obesity via the gut/brain axis

2022 120 citations Kumaran Sundaram, Jingyao Mu et al. Theranostics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald W. Dryden United States	19	749	313	258	229	175	67	1.6k
Lanlan Geng China	23	692 0.9×	269 0.9×	163 0.6×	273 1.2×	259 1.5×	72	1.8k
Tingting Geng China	22	740 1.0×	351 1.1×	129 0.5×	281 1.2×	98 0.6×	96	1.7k
Jin Zhao China	21	683 0.9×	238 0.8×	116 0.4×	115 0.5×	114 0.7×	114	1.7k
Rui Lin China	20	667 0.9×	172 0.5×	124 0.5×	144 0.6×	159 0.9×	53	1.4k
Amit Kumar Tripathi India	19	704 0.9×	134 0.4×	227 0.9×	190 0.8×	236 1.3×	51	1.6k
Jianguo Wang China	22	550 0.7×	157 0.5×	176 0.7×	152 0.7×	118 0.7×	91	1.5k
Min Jiang China	21	479 0.6×	127 0.4×	275 1.1×	107 0.5×	171 1.0×	46	1.1k
Laurens Kruidenier United Kingdom	18	722 1.0×	157 0.5×	491 1.9×	388 1.7×	257 1.5×	26	1.8k
Yava Jones‐Hall United States	20	674 0.9×	97 0.3×	222 0.9×	349 1.5×	187 1.1×	56	1.5k
Mingsong Li China	21	784 1.0×	122 0.4×	293 1.1×	316 1.4×	181 1.0×	63	1.4k

Countries citing papers authored by Gerald W. Dryden

Since Specialization

Citations

This map shows the geographic impact of Gerald W. Dryden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald W. Dryden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald W. Dryden more than expected).

Fields of papers citing papers by Gerald W. Dryden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald W. Dryden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald W. Dryden. The network helps show where Gerald W. Dryden may publish in the future.

Co-authorship network of co-authors of Gerald W. Dryden

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald W. Dryden. A scholar is included among the top collaborators of Gerald W. Dryden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald W. Dryden. Gerald W. Dryden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sundaram, Kumaran, Yun Teng, Jingyao Mu, et al.. (2024). Outer Membrane Vesicles Released from Garlic Exosome‐like Nanoparticles (GaELNs) Train Gut Bacteria that Reverses Type 2 Diabetes via the Gut‐Brain Axis. Small. 20(20). e2308680–e2308680. 44 indexed citations

Lei, Chao, Chao Luo, Zhishan Xu, et al.. (2024). Bacterial and host fucosylation maintain IgA homeostasis to limit intestinal inflammation in mice. Nature Microbiology. 10(1). 126–143. 8 indexed citations

Ghosh, Sweta, Rajbir Singh, Omprakash Sunnapu, et al.. (2024). Inflammation-targeted delivery of Urolithin A mitigates chemical- and immune checkpoint inhibitor-induced colitis. Journal of Nanobiotechnology. 22(1). 701–701. 6 indexed citations

Ali, Asem, et al.. (2023). An Automatic Colorectal Polyps Detection Approach for Ct Colonography. 2790–2794.

Sriwastva, Mukesh K., Yun Teng, Jingyao Mu, et al.. (2023). An extracellular vesicular mutant KRAS‐associated protein complex promotes lung inflammation and tumor growth. Journal of Extracellular Vesicles. 12(2). e12307–e12307. 5 indexed citations

D’Haens, Geert, Jakob Benedict Seidelin, Andreas Lügering, et al.. (2023). Tu1705 DELAYED CLINICAL RESPONSE IN PATIENTS WITH CROHN'S DISEASE RECEIVING UPADACITINIB THERAPY. Gastroenterology. 164(6). S–1085. 2 indexed citations

Liu, Li, Fengyuan Li, Tuo Shao, et al.. (2023). FGF21 Depletion Attenuates Colitis through Intestinal Epithelial IL-22-STAT3 Activation in Mice. Nutrients. 15(9). 2086–2086. 9 indexed citations

Nabeta, Henry W., Maryam Zahin, Joshua L. Fuqua, et al.. (2022). A Phase 1a/1b Clinical Trial Design to Assess Safety, Acceptability, Pharmacokinetics and Tolerability of Intranasal Q-Griffithsin for COVID-19 Prophylaxis. ThinkIR: The University of Louisville's Institutional Repository (University of Louisville). 6(1). 6 indexed citations

Sundaram, Kumaran, Jingyao Mu, Anil Kumar, et al.. (2022). Garlic exosome-like nanoparticles reverse high-fat diet induced obesity via the gut/brain axis. Theranostics. 12(3). 1220–1246. 120 indexed citations breakdown →

10.

Stocker, Abigail, et al.. (2020). Effects of Gastric Neuromodulation on Crohn’s Disease in Patients With Coexisting Symptoms of Gastroparesis. Neuromodulation Technology at the Neural Interface. 23(8). 1196–1200. 2 indexed citations

11.

Carter, Jane, M. Robert Eichenberger, Gerald W. Dryden, et al.. (2017). Genetic polymorphisms predict response to anti-tumor necrosis factor treatment in Crohn’s disease. World Journal of Gastroenterology. 23(27). 4958–4958. 38 indexed citations

12.

Dryden, Gerald W., et al.. (2017). The Role of EGCG on Formation and Secretion of Novel Interleukin-1 Family Cytokines. Gastroenterology. 152(5). S765–S766. 2 indexed citations

13.

Mehta, Minesh P., et al.. (2017). Refractory pouchitis improves after administration of the green tea polyphenol EGCG: a retrospective review. International Journal of Colorectal Disease. 33(1). 83–86. 8 indexed citations

14.

Bhutiani, Neal, William E. Grizzle, Susan Galandiuk, et al.. (2016). Noninvasive Imaging of Colitis Using Multispectral Optoacoustic Tomography. Journal of Nuclear Medicine. 58(6). 1009–1012. 27 indexed citations

15.

Royal, Joshua M., J. Calvin Kouokam, Bodduluri Haribabu, et al.. (2016). Oral administration of a recombinant cholera toxin B subunit promotes mucosal healing in the colon. Mucosal Immunology. 10(4). 887–900. 23 indexed citations

16.

Dryden, Gerald W., et al.. (2013). A Pilot Study to Evaluate the Safety and Efficacy of an Oral Dose of (−)-Epigallocatechin-3-Gallate–Rich Polyphenon E in Patients With Mild to Moderate Ulcerative Colitis. Inflammatory Bowel Diseases. 19(9). 1–1. 93 indexed citations

17.

Wang, Baomei, Xiaoying Zhuang, Zhong-Bin Deng, et al.. (2013). Targeted Drug Delivery to Intestinal Macrophages by Bioactive Nanovesicles Released from Grapefruit. Molecular Therapy. 22(3). 522–534. 460 indexed citations breakdown →

18.

Dryden, Gerald W.. (2009). Overview of biologic therapy for Crohn's disease. Expert Opinion on Biological Therapy. 9(8). 967–974. 20 indexed citations

19.

Studts, Jamie L., et al.. (2008). A Novel Classification Scheme for Gastroparesis Based on Predominant-Symptom Presentation. Journal of Clinical Gastroenterology. 42(5). 455–459. 28 indexed citations

20.

McClain, Craig J., et al.. (2004). Nutritional supplements and alternative medicine. Current Opinion in Gastroenterology. 20(2). 130–138. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact